Tevogen Bio Holdings Inc. Warrant (TVGNW)

Tevogen expressed gratitude to HHS for addressing Long COVID, highlighting its investigational drug TVGN 489 as a potential treatment for the approximately 20 million Americans affected by the condition.

The global AI in healthcare market is projected to reach nearly $700 billion by 2034, growing at 38.5% annually. Companies are developing advanced AI diagnostic technologies targeting areas like diabetic retinopathy, cardiac screening, and chronic disease management, with increasing FDA approvals and commercial potential.